GSK signs £50m deal with Oxford University on cancer vaccines
by Jasper Jolly from Science | The Guardian on (#6TVG9)
Collaboration over at least three years aims to help understand how pre-cancerous cells develop
GSK has said it will spend 50m on a project with the University of Oxford to investigate whether vaccines could be used to prevent some cancers.
The FTSE 100 pharmaceutical company said that the GSK-Oxford Cancer Immuno-Prevention Programme will look at how pre-cancerous cells develop.
Continue reading...